Causes of HyperCKemia in Children: A Retrospective Cohort Study
- 25 December 2022
- journal article
- research article
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 38 (1-2), 25-30
- https://doi.org/10.1177/08830738221147808
Abstract
Background and Objectives: Creatine kinase (CK) is a commonly used screening test for neuromuscular disorders (NMDs). However, hyperCKemia can result from several pathologic and physiologic causes. We analyzed neuromuscular disorders in noninfant children with hyperCKemia including those with no weakness and mild CK elevations (<5 times the upper limit of normal). We hypothesized that children with mild CK elevation and no weakness would be unlikely to have neuromuscular disorders and require additional evaluation. Methods: We retrospectively evaluated patients between 1 and 18 years of age seen at a single children's hospital over a 3-calendar-year period with initial total CK values greater than the upper limit of normal with at least 2 years of follow-up data. Final diagnoses were analyzed and associations with possible risk factors assessed. Receiver operating characteristic curves were generated to assess altering CK cutoff values. Results: Of 260 subjects with hyperCKemia, 18 had a neuromuscular disorder (6.9%, 95% confidence interval [CI] 4.2%-10.9%). Of 166 subjects with CK <5 times the upper limit of normal and no weakness, 8 had a neuromuscular disorder (4.8%, 95% CI 2.3%-9.6%). Weakness (odds ratio [OR] 32.5, 95% CI 4-385, P = .0002), and family history of neuromuscular disorders (OR not calculable, P = .0003) were associated with neuromuscular disorders. An optimal CK threshold of 777 was identified on receiver operating characteristic curve analysis (sensitivity of 72% and specificity of 64%). The most commonly identified neuromuscular disorders were muscular dystrophies, inflammatory myopathies, and metabolic myopathies. Conclusion: Most children with hyperCKemia will not be diagnosed with a neuromuscular disorder, but a significant minority even with mild hyperCKemia and without weakness may warrant additional evaluation.Keywords
This publication has 14 references indexed in Scilit:
- STARD 2015: an updated list of essential items for reporting diagnostic accuracy studiesBMJ, 2015
- Asymptomatic/pauci‐symptomatic creatine kinase elevations (hyperckemia)Muscle & Nerve, 2013
- Variation of serum creatine kinase (CK) levels and prevalence of persistent hyperCKemia in a Norwegian normal population. The Tromsø StudyNeuromuscular Disorders, 2011
- EFNS guidelines on the diagnostic approach to pauci‐ or asymptomatic hyperCKemiaEuropean Journal of Neurology, 2010
- Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosisMuscle & Nerve, 2009
- Effect of newly proposed CK reference limits on neuromuscular diagnosisMuscle & Nerve, 2009
- Distribution of creatine kinase in the general population: Implications for statin therapyAmerican Heart Journal, 2007
- Follow-up of a large population of asymptomatic/oligosymptomatic hyperckemic subjectsZeitschrift für Neurologie, 2006
- Familial idiopathic hyper‐CK‐emia: An underrecognized conditionMuscle & Nerve, 2006
- Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levelsZeitschrift für Neurologie, 2000